+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Ophthalmology Therapeutics Market 2021-2025

  • ID: 4938408
  • Report
  • February 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Ophthalmology Therapeutics Market 2021-2025

The publisher has been monitoring the ophthalmology therapeutics market and it is poised to grow by $12.34 bn during 2021-2025 progressing at a CAGR of 5% during the forecast period. The report on ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven increase in prevalence of eye diseases, , and strong uptake of anti-VEGF inhibitors. In addition, increase in prevalence of eye diseases is anticipated to boost the growth of the market as well.

The ophthalmology therapeutics market analysis includes product segment and geographical landscapes.

The ophthalmology therapeutics market is segmented as below:

By Product
  • Retinal disorder therapeutics
  • Glaucoma therapeutics
  • Dry eye disease therapeutics
  • Eye infections and inflammation therapeutics
  • Other therapeutics

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the approval of novel therapeutics and strong drug pipeline as one of the prime reasons driving the ophthalmology therapeutics market growth during the next few years.

Thereport on ophthalmology therapeutics market covers the following areas:
  • Ophthalmology therapeutics market sizing
  • Ophthalmology therapeutics market forecast
  • Ophthalmology therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ophthalmology therapeutics market vendors that include AbbVie Inc., Aerie Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the ophthalmology therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Retinal disorder therapeutics - Market size and forecast 2020-2025
  • Glaucoma therapeutics - Market size and forecast 2020-2025
  • Dry eye disease therapeutics - Market size and forecast 2020-2025
  • Eye infections and inflammation therapeutics - Market size and forecast 2020-2025
  • Other therapeutics - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer Landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ billion)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Retinal disorder therapeutics - Market size and forecast 2020-2025 ($ billion)
  • Retinal disorder therapeutics - Year-over-year growth 2020-2025 (%)
  • Glaucoma therapeutics - Market size and forecast 2020-2025 ($ billion)
  • Glaucoma therapeutics - Year-over-year growth 2020-2025 (%)
  • Dry eye disease therapeutics - Market size and forecast 2020-2025 ($ billion)
  • Dry eye disease therapeutics - Year-over-year growth 2020-2025 (%)
  • Eye infections and inflammation therapeutics - Market size and forecast 2020-2025 ($ billion)
  • Eye infections and inflammation therapeutics - Year-over-year growth 2020-2025 (%)
  • Other therapeutics - Market size and forecast 2020-2025 ($ billion)
  • Other therapeutics - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ billion)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ billion)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ billion)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ billion)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Aerie Pharmaceuticals Inc. - Overview
  • Aerie Pharmaceuticals Inc. - Business segments
  • Aerie Pharmaceuticals Inc. - Key offerings
  • Aerie Pharmaceuticals Inc. - Key customers
  • Aerie Pharmaceuticals Inc. - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Key customers
  • Otsuka Holdings Co. Ltd. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Regeneron Pharmaceuticals Inc. - Overview
  • Regeneron Pharmaceuticals Inc. - Business segments
  • Regeneron Pharmaceuticals Inc. - Key offerings
  • Regeneron Pharmaceuticals Inc. - Key customers
  • Regeneron Pharmaceuticals Inc. - Segment focus
  • Santen Pharmaceutical Co. Ltd. - Overview
  • Santen Pharmaceutical Co. Ltd. - Business segments
  • Santen Pharmaceutical Co. Ltd. - Key offerings
  • Santen Pharmaceutical Co. Ltd. - Key customers
  • Santen Pharmaceutical Co. Ltd. - Segment focus
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Key customers
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
The publisher recognizes the following companies as the key players in the global ophthalmology therapeutics market: AbbVie Inc., Aerie Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is approval of novel therapeutics and strong drug pipeline.'

According to the report, one of the major drivers for this market is the increase in prevalence of eye diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown